AVGR Key Statistics, Chart & Performance
The current stock price of AVGR is 0.474 USD. In the past month the price decreased by -19.65%. In the past year, price decreased by -84.07%.
AVGR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.11 | 217.86B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.78 | 200.77B | ||
| BSX | BOSTON SCIENTIFIC CORP | 32.32 | 141.35B | ||
| SYK | STRYKER CORP | 26.69 | 134.41B | ||
| BDX | BECTON DICKINSON AND CO | 13.46 | 55.39B | ||
| IDXX | IDEXX LABORATORIES INC | 53.65 | 54.02B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.17 | 49.47B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.87 | 37.36B | ||
| RMD | RESMED INC | 24.33 | 35.16B | ||
| DXCM | DEXCOM INC | 35.68 | 25.89B | ||
| PODD | INSULET CORP | 62.2 | 20.00B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.11 | 17.82B |
Related stock screener links
About AVGR
Company Profile
Avinger, Inc. is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. The company is headquartered in Redwood City, California and currently employs 68 full-time employees. The company went IPO on 2015-01-30. The firm designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. The company has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).
Company Info
Avinger Inc
400 Chesapeake Dr
Redwood City CALIFORNIA 94063 US
CEO: Jeffrey M. Soinski
Employees: 71
Phone: 16503632400
Avinger Inc / AVGR FAQ
What does Avinger Inc do?
Avinger, Inc. is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. The company is headquartered in Redwood City, California and currently employs 68 full-time employees. The company went IPO on 2015-01-30. The firm designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. The company has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).
Can you provide the latest stock price for Avinger Inc?
The current stock price of AVGR is 0.474 USD. The price decreased by -20.74% in the last trading session.
Does AVGR stock pay dividends?
AVGR does not pay a dividend.
What is the ChartMill technical and fundamental rating of AVGR stock?
AVGR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Would investing in Avinger Inc be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AVGR.
Who owns Avinger Inc?
You can find the ownership structure of Avinger Inc (AVGR) on the Ownership tab.
AVGR Technical Analysis
AVGR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AVGR. AVGR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
AVGR Financial Highlights
Over the last trailing twelve months AVGR reported a non-GAAP Earnings per Share(EPS) of -11.03. The EPS increased by 66.4% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -127.59% | ||
| ROE | -447.82% | ||
| Debt/Equity | 0 |
AVGR Forecast & Estimates
7 analysts have analysed AVGR and the average price target is 5.1 USD. This implies a price increase of 975.95% is expected in the next year compared to the current price of 0.474.
For the next year, analysts expect an EPS growth of -30.64% and a revenue growth -12.9% for AVGR